N@N

Yifeng Liu Maintained (BNTX) at Strong Buy with Increased Target to $136 on, Oct 7th, 2024

Yifeng Liu of HSBC, Maintained "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $97 to $136 on, Oct 7th, 2024.

Yifeng has made no other calls on BNTX in the last 4 months.

There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 3 agree with Yifeng's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Eliana Merle of "UBS" Maintained at Hold with Increased Target to $131 on, Wednesday, September 18th, 2024
• Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
• Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024

These are the ratings of the 4 analyists that currently disagree with Yifeng

---

• Terence Flynn of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $145 on, Tuesday, September 24th, 2024
• Emmanuel Papadakis of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $150 on, Thursday, September 19th, 2024
• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $150 on, Tuesday, September 17th, 2024
• Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024